Cargando…

Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial

BACKGROUND: Induction therapy with IL-2 receptor antagonist (IL2-RA) is recommended as a first-line agent in low immunological risk kidney transplant recipients. However, the role of IL2-RA in the setting of tacrolimus-based immunosuppression has not been fully investigated. AIMS: To compare differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajlan, Aziza, Aleid, Hassan, Ali, Tariq Zulfiquar, Joharji, Hala, Almeshari, Khalid, Nazmi, Ahmed Mohammed, Shah, Yaser, Devol, Edward, Alkortas, Dalal, Alabdulkarim, Zinah, Broering, Dieter, Alahmadi, Ibrahim, Ullah, Asad, Alotaibi, Anwar, Aljedai, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223264/ https://www.ncbi.nlm.nih.gov/pubmed/34167567 http://dx.doi.org/10.1186/s13063-021-05253-1

Ejemplares similares

Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control
por: Joharji, Hala, et al.
Publicado: (2022)

Efficacy of basiliximab induction in poorly matched living donor renal transplantation
por: Gundlapalli, S., et al.
Publicado: (2013)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Basiliximab Induction with Delayed Calcineurin Inhibitors for High-Risk Lung Transplant Candidates
por: Kim, Ha Eun, et al.
Publicado: (2021)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)

Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study
por: Ajlan, Aziza A., et al.
Publicado: (2022)

Basiliximab induction therapy in kidney transplantation: Benefits for long term allograft function after 10 years?
por: Koch, Martina, et al.
Publicado: (2009)

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
por: Ansari, David, et al.
Publicado: (2015)

Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies
por: Kim, Hyung Duk, et al.
Publicado: (2023)

Lymphocytes as an Indicator for Initial Kidney Function: A Single Center Analysis of Outcome after Alemtuzumab or Basiliximab Induction
por: Weissenbacher, Annemarie, et al.
Publicado: (2015)

Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)

Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry
por: Lee, Jun Young, et al.
Publicado: (2022)

Outcomes of Kidney Transplantation in Older Recipients
por: Hammad, Ehab, et al.
Publicado: (2023)

The role of basiliximab in the evolving renal transplantation immunosuppression protocol
por: Salis, Paola, et al.
Publicado: (2008)

Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk – a retrospective analysis of UNOS database
por: Ali, Hatem, et al.
Publicado: (2023)

Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients
por: Ajlan, A., et al.
Publicado: (2016)

Mpox Perceptions and Vaccine Advocacy among the Healthcare Workers of Solid Organ Transplant Centers: A Multicenter, Cross-Sectional Survey in Saudi Arabia
por: Alhasan, Khalid, et al.
Publicado: (2023)

Tacrolimus-Induced Neurotoxicity in Early Post-Liver Transplant Saudi Patients: Incidence and Risk Factors
por: Alissa, Dema A., et al.
Publicado: (2022)

Basiliximab/steroids/tacrolimus: Pneumonia with Scedosporium apiospermum and Lomentospora prolificans: case report
Publicado: (2021)

Enhancer activation by FGF signalling during otic induction
por: Tambalo, Monica, et al.
Publicado: (2020)

NFAT5/STAT3 interaction mediates synergism of high salt with IL-17 towards induction of VEGF-A expression in breast cancer cells
por: Amara, Suneetha, et al.
Publicado: (2016)

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Treating a GAD65 Antibody-Associated Limbic Encephalitis with Basiliximab: A Case Study
por: Widman, Guido, et al.
Publicado: (2015)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Thymoglobulin Versus Alemtuzumab Versus Basiliximab Kidney Transplantation From Donors After Circulatory Death
por: Asderakis, Argiris, et al.
Publicado: (2022)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report
por: Ijiri, Naohiro, et al.
Publicado: (2022)

Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients
por: Masset, Christophe, et al.
Publicado: (2023)

Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report
por: Zarrabi, Maiah, et al.
Publicado: (2023)

Genome-Based Prediction of Time to Curd Induction in Cauliflower
por: Rosen, Arne, et al.
Publicado: (2018)

Comparison of different ratios of propofol-ketamine admixture in rapid-sequence induction of anesthesia for emergency laparotomy: a randomized controlled trial
por: Elsherbiny, Mona, et al.
Publicado: (2023)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients
por: Kamar, Nassim, et al.
Publicado: (2020)

The Effect of Monthly Anti-CD25(+) Treatment with Basiliximab on the Progression of Chronic Renal Dysfunction after Lung Transplantation
por: Ross, D. J., et al.
Publicado: (2020)

The comparative efficacy and safety of basiliximab and antithymocyte globulin in deceased donor kidney transplantation: a multicenter cohort study
por: Hong, Su Yeon, et al.
Publicado: (2023)

Induction parabolique et induction parahorique
por: Dat, J F
Publicado: (2002)

Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
por: López-Abente, Jacobo, et al.
Publicado: (2021)

Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report
por: Chen, Tingting, et al.
Publicado: (2022)

Pharmacists roles and responsibilities during epidemics and pandemics in Saudi Arabia: An opinion paper from the Saudi Society of clinical pharmacy
por: Badreldin, Hisham A., et al.
Publicado: (2020)

Possibilities Of Inductive Storage Circuits In Induction linacs
por: Bobylev, V I
Publicado: (1990)

Induction with rATG versus No-induction in Deceased Donor Renal Transplantation – A Retrospective Observational Study
por: Dwivedi, Rohan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qutsvtjn5rvcnishq5qq7bbp7